FirstRanker Logo

FirstRanker.com - FirstRanker's Choice is a hub of Question Papers & Study Materials for B-Tech, B.E, M-Tech, MCA, M.Sc, MBBS, BDS, MBA, B.Sc, Degree, B.Sc Nursing, B-Pharmacy, D-Pharmacy, MD, Medical, Dental, Engineering students. All services of FirstRanker.com are FREE

📱

Get the MBBS Question Bank Android App

Access previous years' papers, solved question papers, notes, and more on the go!

Install From Play Store

Download OU M.Pharma Pharmaceutics 1st Sem 2019 13150PCI Regulatory Affairs Question Paper

Download OU (Osmania University) M.Pharma-Pharmaceutics (Master of Pharmacy) 1st Sem 2019 13150PCI Regulatory Affairs Previous Question Paper

This post was last modified on 19 July 2020

OU M.Pharm Question Papers Last 10 Years 2010-2020 || Osmania University


FirstRanker.com

FACULTY OF PHARMACY

M. Pharmacy (Pharmaceutics) I-Semester (Main & Backlog) Examination, February 2019

--- Content provided by‌ FirstRanker.com ---

Subject : Regulatory Affairs

Time: 3 Hrs Max. Marks: 75

Note: Answer any Five Questions. All Questions Carry Equal Marks.

  1. (a) Describe various parts of master formula record and write its importance. 7
    (b) Explain salient features of Hatch Waxman Act and its amendments. 8
  2. --- Content provided by​ FirstRanker.com ---

  3. Enlist different sections of NDA and Write a note on NDA approval process. 15
  4. (a) Explain regulatory requirements of US registration for foreign drugs. 8
    (b) Explain SUPAC guidelines specific to manufacturing changes 7
  5. (a) Describe the objectives of harmonization guidelines. Enlist ICH quality guidelines. 10
    (b) Explain the objectives of CMC considerations during drug development. 5
  6. --- Content provided by FirstRanker.com ---

  7. (a) Explain the regulatory requirement for biologics product approval. 8
    (b) What is the purpose of Investigator’s Brochure? Give a brief note on the Information to be filled in each part of the IB. 7
  8. (a) Write a note on eCTD. 7
    (b) Write different designs of BE studies for Generic drugs assessment. 8
  9. (a) Give an outline of factors that must be addressed in the clinical trial protocols as per USFDA check list. 8

    --- Content provided by​ FirstRanker.com ---

    (b) Give a brief note on Pharmacovigilance and safety monitoring in clinical trials. 7
  10. Write brief notes on:
    1. Regulatory requirements of EU 7
    2. Health Insurance Portability and Accountability Act. 8

--- Content provided by​ FirstRanker.com ---


This download link is referred from the post: OU M.Pharm Question Papers Last 10 Years 2010-2020 || Osmania University